Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Endocrine Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03322995
What this trial is testing

Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

Who this might be right for
Pancreatic Cancer
Medical College of Wisconsin 125
Testing effectiveness (Phase 2)Study completedNCT00020345
What this trial is testing

Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas

Who this might be right for
Stage IVA Pancreatic CancerStage III Pancreatic CancerAdenocarcinoma of the Pancreas
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Study completedNCT01470417
What this trial is testing

Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
University of Florida 10
Post-approval studies (Phase 4)UnknownNCT03111615
What this trial is testing

HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer

Who this might be right for
Hormone Dependent NeoplasmsBreast Cancer Female
Centro Hospitalar Lisboa Ocidental 90
Testing effectiveness (Phase 2)Looking for participantsNCT06806930
What this trial is testing

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+1 more
George Washington University 90
Not applicableUnknownNCT05262452
What this trial is testing

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy EffectUltrasound Therapy
Seoul National University Hospital 60
Not applicableUnknownNCT04997252
What this trial is testing

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

Who this might be right for
High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Not applicableNot Yet RecruitingNCT07311915
What this trial is testing

Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study

Who this might be right for
Prostate Cancer
Zhongda Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03219476
What this trial is testing

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Who this might be right for
Breast CancerInvasive Breast Cancer
Medical College of Wisconsin 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02451982
What this trial is testing

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 76
Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477418
What this trial is testing

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic CancerPancreatic Neoplasms
University of Vermont 10
Not applicableStudy completedNCT01027221
What this trial is testing

Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer

Who this might be right for
Primarily Resectable Pancreatic Cancer
German Cancer Research Center 32
Not applicableStudy completedNCT00763516
What this trial is testing

Proton Radiation for Resectable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Florida 8
Testing effectiveness (Phase 2)UnknownNCT04524884
What this trial is testing

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Who this might be right for
Thyroid Cancer
Fudan University 10
Large-scale testing (Phase 3)Study completedNCT00535418
What this trial is testing

Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 35
Not applicableLooking for participantsNCT07542041
What this trial is testing

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)+1 more
ARTIDIS AG 200
Large-scale testing (Phase 3)UnknownNCT04753177
What this trial is testing

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Who this might be right for
The Neoadjuvant Therapy
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Next Page